Olux-E Approval History
Olux-E (clobetasol propionate) is a topical steroid formulated in VersaFoam emulsion foam drug delivery vehicle indicated for the treatment of psoriasis and eczema in patients 12 years of age or older.
Development History and FDA Approval Process for Olux-E
|Jan 12, 2007||Olux-E Stiefel Laboratories, Inc. - Treatment for Psoriasis and Eczema|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.